Cycas revoluta

From WikiMD's WELLNESSPEDIA

Cycas revoluta, also known as the Sago Palm, is a species of gymnosperm in the family Cycadaceae, native to southern Japan. Despite its common name, it is not a true palm.

Description[edit]

Cycas revoluta is an evergreen perennial plant that can grow up to 10 meters tall. The leaves are a deep semigloss green and about 50–150 cm long when mature. It is a dioecious species, with male and female reproductive organs occurring on separate plants.

Distribution and habitat[edit]

Cycas revoluta is native to the Ryukyu Islands and other parts of southern Japan. It grows in habitats that include scrub and dry forests.

Cultivation[edit]

Cycas revoluta is one of the most widely cultivated cycads, grown outdoors in warm temperate and subtropical regions, or under glass in colder areas. It grows best in sandy, well-drained soil, and prefers full sun to light shade.

Uses[edit]

The pith contains edible starch, and is used for making sago. In addition to its use as a food source, Cycas revoluta is also popular as an ornamental plant in gardens and parks.

Toxicity[edit]

All parts of the plant are toxic to animals if ingested, due to the presence of cycasin, a toxin that can cause vomiting, liver failure, and death.

Conservation[edit]

Cycas revoluta is listed as a species of least concern on the IUCN Red List due to its wide distribution and large population.

See also[edit]




This article is a stub related to food. You can help WikiMD by expanding it!


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.